Academic Publications

US-based philosopher, researcher, and psychedelic integration guide with a Master's degree in philosophy focused on the nature of healing in the psychedelic experience, who has worked as a research assistant at a ketamine clinic and written curriculum for multiple psychedelic therapy certificate programs. Criddle offers a Philosophy and Psychedelics online course and integration coaching, has contributed to Blossom Analysis and Psychedelic Science Review, and co-produced the documentary EntheoMagus exploring the psychedelic origins of Mormonism and the role of entheogens in American occultism.

Psychedelic science education platform founded by British neurobiologist and pharmacologist Andrew R. Gallimore in Tokyo, focused on the neuroscience of DMT, consciousness, and psychedelic pharmacology. Gallimore co-authored a landmark 2016 paper with Rick Strassman proposing target-controlled intravenous DMT infusion for sustained immersive experiences, and publishes the Alien Insect On Drugs Substack alongside immersive educational workshops.

The American Academy of Child and Adolescent Psychiatry (AACAP) is a major US professional medical association representing child and adolescent psychiatrists and publisher of the Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP). The organization and its journal have actively engaged with questions around psychedelic-assisted therapy for youth, publishing clinical research and ethical analyses on the potential use of psilocybin and MDMA in adolescent populations.

The American Psychiatric Association (APA) is the world's largest psychiatric professional association with over 37,000 physician members, and publisher of the American Journal of Psychiatry and the DSM diagnostic standards. In 2022 the APA issued a landmark position statement on psychedelics, acknowledging promising early evidence for psilocybin and MDMA-assisted therapy while calling for rigorous research and caution against clinical use outside approved investigational settings.

Dr. Anna Rose Childress is a Research Associate Professor of Psychology in Psychiatry at the University of Pennsylvania Perelman School of Medicine and Director of the Brain-Behavioral Vulnerabilities Laboratory at the Center for Studies of Addiction, with over four decades of NIDA-funded research on brain reward circuits and craving in substance use disorders. She is now advancing into psilocybin research, contributing to Penn's clinical trial of psilocybin for opioid use disorder and publicly addressing regional barriers to psychedelic-assisted therapy.